Roche Holding AG reported a robust performance for the full year of 2024, with sales reaching 60.5 billion Swiss francs, marking a 7% increase at constant exchange rates and a 3% rise in Swiss francs from the previous year. The company's fourth-quarter revenue was 15.51 billion Swiss francs, slightly above the estimated 15.48 billion Swiss francs. For the full year, core operating profit stood at 20.82 billion Swiss francs, falling short of the expected 21.05 billion Swiss francs, while core earnings per share (EPS) were 18.80 Swiss francs, surpassing the forecast of 18.49 Swiss francs. Looking ahead to 2025, Roche anticipates sales growth in the mid-single-digit range and projects high single-digit growth in core profit. The company also raised its dividend following the strong annual results, which included a 9% growth in the fourth quarter. CEO Thomas Schinecker expressed confidence in the company's momentum continuing into 2025, citing a strong performance in 2024.